Nanjing Well Pharmaceutical Group Co.,Ltd. (603351.SS)

CNY 23.8

(0.68%)

Annual Balance Sheets

(In CNY)
Breakdown 2023 2022 2021 2020 2019 2018
Total Assets 2.27 Billion 2.13 Billion 1.84 Billion 1.63 Billion 1.45 Billion 808.19 Million
Total Current Assets 599.42 Million 470.28 Million 464.69 Million 500.54 Million 823.29 Million 318.25 Million
Cash And Short Term Investments 158.79 Million 100.93 Million 92.5 Million 272.26 Million 271.24 Million 40.43 Million
Cash and Cash Equivalents 157.54 Million 99.82 Million 66.26 Million 75.55 Million 180.93 Million 40.43 Million
Short Term Investments 1.25 Million 1.1 Million 26.23 Million 196.71 Million 90.31 Million -
Net Receivables 263.19 Million 186.75 Million 216.44 Million 113.04 Million 183 Million 167.06 Million
Inventory 170.57 Million 165.12 Million 142.44 Million 115.04 Million 114.88 Million 100.88 Million
Other Current Assets 6.85 Million 17.46 Million 13.3 Million 186.37 Thousand 254.16 Million 9.86 Million
Total Non-Current Assets 1.67 Billion 1.66 Billion 1.37 Billion 1.13 Billion 634.97 Million 489.94 Million
Net PPE 1.49 Billion 1.48 Billion 1.21 Billion 940.8 Million 500.65 Million 369.31 Million
Good Will And Intangible Assets 98.37 Million 93.52 Million 77.48 Million 78.49 Million 80.14 Million 42.48 Million
Good Will - - - - - -
Intangible Assets 98.37 Million 93.52 Million 77.48 Million 78.49 Million 80.14 Million 42.48 Million
Long-Term Investments 70.04 Million 67.68 Million 13.76 Million -156.71 Million 4.18 Million 664.89 Thousand
Tax Assets 9.25 Million 5.98 Million 11.69 Million 1.42 Million 1.26 Million 1.75 Million
Other Non Current Assets 2.83 Million 19.01 Million 62.08 Million 271.86 Million 48.73 Million 75.72 Million
Other Assets 1.00 1.00 1.00 1.00 - -
Total Liabilities 686.22 Million 655.75 Million 456.01 Million 336.75 Million 217.05 Million 193.58 Million
Total Current Liabilities 557.74 Million 580.02 Million 422.69 Million 307.62 Million 198.98 Million 180.64 Million
Account Payables 105.82 Million 124.54 Million 144.33 Million 168.44 Million 68.85 Million 59.29 Million
Tax Payables 13.32 Million 24.84 Million 1.16 Million 7.57 Million 5.18 Million 4.71 Million
Short Term Debt 382.89 Million 369.67 Million 186.29 Million 104.85 Million 102.21 Million 94.76 Million
Deferred Revenue 67.99 Million 9.09 Million 89.94 Million 33.32 Million 22.73 Million 4.71 Million
Other Current Liabilities 1.03 Million 76.71 Million 2.11 Million 1 Million 5.18 Million 21.87 Million
Total Non Current Liabilities 128.47 Million 75.73 Million 33.31 Million 29.12 Million 18.07 Million 12.94 Million
Long-Term Debt 104.06 Million 56.38 Million 13.59 Million 11.41 Million - -
Deferred Revenue Non Current 12.71 Million 6.5 Million 6.74 Million 6 Million 7.02 Million 9.91 Million
Deferred Tax Liabilities Non Current - - - - - -
Other Non Current Liabilities 2.00 1.00 - - 1.00 1.00
Other Liabilities 1.00 - - 1.00 - -
Total Equity 1.59 Billion 1.48 Billion 1.38 Billion 1.29 Billion 1.24 Billion 614.6 Million
Stock Holders Equity 1.58 Billion 1.48 Billion 1.38 Billion 1.29 Billion 1.24 Billion 614.6 Million
Common Stock 135.43 Million 135.47 Million 135.47 Million 130.66 Million 93.33 Million 50 Million
Retained Earnings 456.66 Million 382.51 Million 330.9 Million 280.09 Million 231.94 Million 156.89 Million
Accumulated other comprehensive income 106.07 Million 75.65 Million 29.67 Million 46.71 Million 36.41 Million 23.35 Million
Common Stock Equity 1.58 Billion 1.48 Billion 1.38 Billion 1.29 Billion 1.24 Billion 614.6 Million
Capital Lease Obligation 18.76 Million 16.38 Million 13.59 Million - - -
Total Investments 71.29 Million 68.79 Million 40 Million 40 Million 90.31 Million 664.89 Thousand
Total Debt 486.95 Million 426.06 Million 199.89 Million 116.27 Million 102.21 Million 94.76 Million
Net Debt 329.41 Million 326.23 Million 133.62 Million 40.71 Million -78.71 Million 54.32 Million

Balance Sheet Charts